throughout the PCC has not been described. This systematic review aims to: 1) identify and collate outcome measure (OM) definitions for the PCC stages; 2) describe how key health equity characteristics are considered in these OM definitions. Methods Five databases were searched for quantitative studies published after January 1st, 2012. Data regarding study design, OM definitions, and health equity characteristics were extracted. Data were analysed using narrative synthesis. Results 11,264 papers were identified and screened; 227 were included. The majority of studies included >1 OM (67%). The most commonly reported OM was awareness (54%), followed by interest (51%) and uptake (50%). Relatively few studies reported on adherence (12%) or retention (17%). No studies described movement through the PCC from awareness to retention. The most commonly reported equity characteristics were age (86%) and race/ ethnicity (80%); the least common were social capital (31%) and religion (1%). The majority of studies focused on cis-gender men who have sex with men (MSM) (48%), while other affected groups, such as cis-gender women and trans\* people are less well represented (7% and 6%, respectively). Conclusion There is an unequal focus on the earlier stages of the PCC. Some key equity characteristics (e.g. age) are commonly considered, however, other important characteristics (e. g. social capital) are overlooked. These findings are relevant to healthcare professionals, policymakers and commissioners in informing how to best implement and evaluate PrEP programmes for potentially vulnerable and less advantaged populations.

scihub/10.1136/sextrans-2021-sti.278.pdf

S Bogers; M Schim van der Loeff; U Davidovich; A Boyd; M van der Valk; K Brinkman; G de Bree; P Reiss; J van Bergen; S Geerlings

pages A106.1-A106, 2021 jul

sci-hub for update

{"container_title":"Poster presentations","content":{"parsed_at":1715441346,"parser":{"name":"textparser","version":"0.1.129"},"source":{"name":"grobid","version":"0.8.0"}},"event":{"name":"Abstracts for the STI & HIV World Congress, July 14–17 2021"},"publisher":"BMJ Publishing Group Ltd"}

2021-10-21